13/08/2026
A drug that blocks iron export already helps β-thalassemia patients' anemia — but what does it do to their bones?
That question mattered because similar iron-pathway drugs have made bone loss worse, not better. Testing VIT-2763 directly in a mouse model, researchers found the opposite: it left bone-building cells alone but slowed the bone-resorbing ones.
Label-free helped show how — live imaging revealed two key resorption proteins suppressed inside osteoclasts, and under iron-overload conditions, cell density rose even though shape stayed the same, a physical signature linked to the drug's protective effect.
Read the study: https://doi.org/10.1038/s41420-026-03273-x